Skip to main content
Erschienen in: Annals of Hematology 8/2019

11.03.2019 | Letter to the Editor

Clinicohematologic and cytogenetic profile in a rare case of pure erythroid leukemia

verfasst von: Smeeta Gajendra, Anil Kumar Yadav, Bhuvan Chugh, Nitin Sood, Manorama Bhargava

Erschienen in: Annals of Hematology | Ausgabe 8/2019

Einloggen, um Zugang zu erhalten

Excerpt

Dear Editor, …
Literatur
1.
Zurück zum Zitat Wang W, Wang SA, Medeiros LJ, Khoury JD (2017) Pure erythroid leukemia. Am J Hematol 92(3):292–296CrossRefPubMed Wang W, Wang SA, Medeiros LJ, Khoury JD (2017) Pure erythroid leukemia. Am J Hematol 92(3):292–296CrossRefPubMed
2.
Zurück zum Zitat Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, Bloomfield CD, Cazzola M, Vardiman JW (2016) The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 127(20):2391–2405CrossRefPubMed Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, Bloomfield CD, Cazzola M, Vardiman JW (2016) The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 127(20):2391–2405CrossRefPubMed
3.
Zurück zum Zitat Reinig EF, Greipp PT, Chiu A, Howard MT, Reichard KK (2018) De novo pure erythroid leukemia: refining the clinicopathologic and cytogenetic characteristics of a rare entity. Mod Pathol 31(5):705–717CrossRefPubMed Reinig EF, Greipp PT, Chiu A, Howard MT, Reichard KK (2018) De novo pure erythroid leukemia: refining the clinicopathologic and cytogenetic characteristics of a rare entity. Mod Pathol 31(5):705–717CrossRefPubMed
4.
Zurück zum Zitat Hasserjian RP (2013) Erythroleukemia and its differential diagnosis. Surg Pathol Clin 6(4):641–659CrossRefPubMed Hasserjian RP (2013) Erythroleukemia and its differential diagnosis. Surg Pathol Clin 6(4):641–659CrossRefPubMed
5.
Zurück zum Zitat Montalban-Bravo G, Benton CB, Wang SA, Ravandi F et al (2016) Pure erythroid leukemia is characterized by TP53mutations, a complex karyotype with chromosome 17 abnormalities, and adverse risk independent of therapy type. Blood. 128(22):2852 Montalban-Bravo G, Benton CB, Wang SA, Ravandi F et al (2016) Pure erythroid leukemia is characterized by TP53mutations, a complex karyotype with chromosome 17 abnormalities, and adverse risk independent of therapy type. Blood. 128(22):2852
6.
Zurück zum Zitat Liu W, Hasserjian RP, Hu Y, Zhang L, Miranda RN, Medeiros LJ, Wang SA (2011) Pure erythroid leukemia: a reassessment of the entity using the 2008 World Health Organization classification. Mod Pathol 24(3):375–383CrossRefPubMed Liu W, Hasserjian RP, Hu Y, Zhang L, Miranda RN, Medeiros LJ, Wang SA (2011) Pure erythroid leukemia: a reassessment of the entity using the 2008 World Health Organization classification. Mod Pathol 24(3):375–383CrossRefPubMed
Metadaten
Titel
Clinicohematologic and cytogenetic profile in a rare case of pure erythroid leukemia
verfasst von
Smeeta Gajendra
Anil Kumar Yadav
Bhuvan Chugh
Nitin Sood
Manorama Bhargava
Publikationsdatum
11.03.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Annals of Hematology / Ausgabe 8/2019
Print ISSN: 0939-5555
Elektronische ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-019-03660-8

Weitere Artikel der Ausgabe 8/2019

Annals of Hematology 8/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.